Sanofi-Aventis (France) May Make Hostile Bid If Genzyme Corporation Resists, Citigroup Says

Bloomberg -- Sanofi-Aventis SA may begin a hostile bid for Genzyme Corp. should the U.S. biotechnology company resist a takeover approach, analysts at Citgroup Inc. said.